Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06357845 · ClinicalTrials.gov registry record · NA
Linking Somatic Mutation Rate With Baseline Exposure in East Palestine
A NA study of Somatic Mutation, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT06357845 is a NA study of Somatic Mutation that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06357845, a NA study of Somatic Mutation, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to This research team is conducting this study to develop methods to measure the biological impact of exposure to the chemicals released following the February 3, 2023 train derailment on residents of East Palestine, Ohio, and surrounding communities. The main question it aims to answer is: * What biological impact will be measured based on DNA damage? * In participants who provide a biospecimen, how are biomarker changes related to proximity to the derailment and variations in residents' health histories and behaviors? Participants will: * Complete a brief survey asking about experiences related to the February 3, 2023 train derailment, health experiences, and concerns following the derailment, and background information regarding health history. * Possibly contribute biospecimens such as blood, spit, hair, and/or toenail clippings. * Receive communication about study updates and future research opportunities. * A total of 40 study participants will be recruited to participate in a 90-minute interview. The interviews will be video and audio recorded.
Conditions Studied
Interventions
- OTHER Survey
- OTHER Biological specimen collection
- OTHER Communications about study updates and future research opportunities
- OTHER Qualitative interview
Study Locations (1)
Ohio
- Case Western Reserve University, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-08-16 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06357845
The ClinicalTrials.gov registry entry for NCT06357845 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Somatic Mutation appearing as the primary indexed condition, and to 4 interventions - of which Survey is the first listed.
NCT06357845 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06357845 about?
NCT06357845 is a clinical study titled "Linking Somatic Mutation Rate With Baseline Exposure in East Palestine". The goal of this study is to This research team is conducting this study to develop methods to measure the biological impact of exposure to the chemicals released following the February 3, 2023 train derailment on residents of East Palestine, Ohio, and surrounding communities. The main question it a...
What is the current status of trial NCT06357845?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2024-08-16. Estimated completion is 2026-09-30.
What conditions does trial NCT06357845 study?
This clinical trial studies the following conditions: Somatic Mutation.
What interventions are being tested in trial NCT06357845?
The interventions under investigation include: Survey (OTHER), Biological specimen collection (OTHER), Communications about study updates and future research opportunities (OTHER), Qualitative interview (OTHER).
Who is sponsoring clinical trial NCT06357845?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06357845 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Somatic Mutation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.